- decreased bone mineral density / IMPC
- abnormal vocalization / IMPC
- abnormal retina vasculature morphology / IMPC
- increased circulating alanine transaminase level / IMPC
- increased circulating chloride level / IMPC
- decreased lean body mass / IMPC
- decreased spleen weight / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased total body fat amount / IMPC
- abnormal retina blood vessel morphology / IMPC
- preweaning lethality, complete penetrance / IMPC
- increased total retina thickness / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6NCrl-Eif4g1em1(IMPC)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:13721 |
International strain name | C57BL/6NCrl-Eif4g1em1(IMPC)Hmgu/Ieg |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Eif4g1em1(IMPC)Hmgu |
Gene/Transgene symbol | Eif4g1 |
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating chloride level / IMPC
- decreased spleen weight / IMPC
- increased total retina thickness / IMPC
- abnormal retina vasculature morphology / IMPC
- abnormal vocalization / IMPC
- increased fasting circulating glucose level / IMPC
- increased total body fat amount / IMPC
- preweaning lethality, complete penetrance / IMPC
- abnormal retina blood vessel morphology / IMPC
- decreased lean body mass / IMPC
- increased circulating alanine transaminase level / IMPC
- decreased bone mineral density / IMPC
- increased circulating aspartate transaminase level / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).